Puri Raj K. Insider Trades

Insider Trading History

Track insider trading activity for Puri Raj K.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $71.1k 15,000 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60.5k 15,000 shares
$4.03
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.19M 251,957 shares
Last Trade
Jun 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$41.3k 9,766 shares
$4.23
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $324k 68,365 shares
Last Trade
Jun 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$41.3k 9,766 shares
$4.23
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.18M 248,114 shares
Last Trade
Jun 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.3k 3,843 shares
$4.23
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $77.8k 16,409 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$21.7k 5,469 shares
$3.96
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.16M 244,699 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$21.7k 5,469 shares
$3.96
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.15M 242,191 shares
Last Trade
Jun 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.93k 2,508 shares
$3.96
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $557k 117,500 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$636k 117,500 shares
$5.41
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.22M 257,590 shares
Last Trade
Mar 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$179k 39,059 shares
$4.58
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $370k 78,131 shares
Last Trade
Mar 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$179k 39,059 shares
$4.58
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.13M 239,230 shares
Last Trade
Mar 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$84.1k 18,360 shares
$4.58
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.04M 218,531 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$10.6k 2,798 shares
$3.79
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $104k 21,878 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.7k 5,470 shares
$3.79
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.05M 221,329 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.7k 5,470 shares
$3.79
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.02M 215,859 shares
Last Trade
Dec 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.5k 2,467 shares
$2.23
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.03M 218,326 shares
Last Trade
Dec 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.2k 5,469 shares
$2.23
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $130k 27,348 shares
Last Trade
Dec 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.2k 5,469 shares
$2.23
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $156k 32,817 shares
Last Trade
Sep 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12k 5,470 shares
$2.19
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.02M 215,324 shares
Last Trade
Sep 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12k 5,470 shares
$2.19
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Regulatory Officer
Holding Value $1.01M 212,857 shares
Last Trade
Sep 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.4k 2,467 shares
$2.19
$4.74

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up